Best Peptides for 2026.
Weight Loss. Skin. Muscle.
All In One Stack.
5-Layer Research
Architecture
Each layer targets a distinct receptor pathway. Non-overlapping. Maximum breadth.
GLP Core
Retatrutide (GLP-3 R)
Triple-receptor agonist. GLP-1R + GIPR + GcgR. The most data-rich compound in its class.
Gut Recovery
BPC-157
GI mucosal integrity during reduced-intake GLP protocols. BPC-157: NO system, VEGFR2, 40+ published studies.
Skin & Glow
GHK-Cu + SNAP-8
GHK-Cu modulates 4,000+ human genes toward repair. SNAP-8 targets SNARE complex NMJ signaling.
Lean Mass
CJC-1295 / Ipamorelin + IGF-1 LR3
GH axis: GHRH receptor amplitude + GHS-R1a frequency. Synergistic pulsatile secretion pattern.
Longevity
Epithalon + NAD+
Telomerase activation (Epithalon) and sirtuin/PARP substrate restoration (NAD+).
5 Core Compounds
>98% HPLC verified · Third-party tested
GLP-1 S vs GLP-2 T vs GLP-3 R
Three receptor pathways. The data explains the 2× outcome gap.
| Metric | GLP-1 S Semaglutide | GLP-2 T Tirzepatide | GLP-3 R★ BestRetatrutide |
|---|---|---|---|
| Compound | Semaglutide | Tirzepatide | Retatrutide |
| Receptor targets | 1 (GLP-1R) | 2 (GLP-1R + GIPR) | 3 (GLP-1R, GIPR, GcgR) |
| Phase 3/2 weight Δ | −14.9% (STEP-1) | −22.5% (SURMOUNT-1) | −28.7% (Phase 2) |
| Trial duration | 68 weeks | 72 weeks | 48 weeks |
| Energy expenditure | Moderate | Moderate + GIPR | High (+ GcgR axis) |
| Side chain mod | C18 fatty diacid | C20 fatty diacid | Lipidated (C18) |
Browse by Peptide Class
GLP Receptor Agonists
GLP-1 S, GLP-2 T, GLP-3 R. Mono, dual, and tri-receptor research.
Gut Recovery
BPC-157 and Teduglutide — mucosal integrity and GI repair.
Skin & Glow
GHK-Cu (4,000+ gene interactions) and SNAP-8 cosmetic research.
Lean Mass & Longevity
GH axis, IGF-1, telomere biology, and cellular energy.
Core Protocol Stack
The complete 5-layer 10-compound research stack.
Build the Stack. Run the Protocol.
All 10 compounds. >98% HPLC purity. Third-party test reports.